THE ROLE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR-2 (PAI-2) IN KERATINOCYTE PROLIFERATION

被引：0
|
作者：
HIBINO, T [1 ]
OONUMA, M [1 ]
TAKAHASHI, T [1 ]
HORII, I [1 ]
机构：
[1] SHISEIDO RES CTR,YOKOHAMA,JAPAN
来源：
CLINICAL RESEARCH | 1992年 / 40卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A514 / A514
页数：1
相关论文
共 50 条
  • [21] EVOLUTION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) IN ORTHOTOPIC LIVER-TRANSPLANTATION (OLT)
    HIMMELREICH, G
    DOOIJEWAARD, G
    BREINL, P
    BECHSTEIN, WO
    NEUHAUS, P
    KLUFT, C
    RIESS, H
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (01) : 56 - 59
  • [22] MEASUREMENT OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) AND DERIVATIVES CONTAINING THE U-PA SERINE PROTEASE DOMAIN
    VANKEER, L
    DECLERCK, PJ
    VERSTREKEN, M
    COLLEN, D
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1268 - 1268
  • [23] DIAGNOSTIC EFFICACY OF PLASMA UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-2 IN DIFFERENTIATION OF HEPATOCELLULAR-CARCINOMA FROM CIRRHOSIS
    SONG, KS
    LEE, A
    CHOI, JR
    KWON, OH
    THROMBOSIS AND HAEMOSTASIS, 1995, 74 (03) : 864 - 867
  • [24] GENE INACTIVATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN MICE
    CARMELIET, P
    SCHOONJANS, L
    STASSEN, JM
    KIECKENS, L
    VANNUFFELEN, A
    DEMOL, M
    COLLEN, D
    MULLIGAN, R
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 764 - 764
  • [25] REGULATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 (PAI-2) GENE-EXPRESSION
    MEDCALF, RL
    RUEGG, M
    SCHLEUNING, WD
    COUSIN, E
    KRUITHOF, EKO
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 867 - 867
  • [26] CHARACTERIZATION OF DOMAIN DELETION AND OR DUPLICATION MUTANTS OF A RECOMBINANT CHIMERA OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (RT-PA/U-PA)
    NELLES, L
    LIJNEN, HR
    VANNUFFELEN, A
    DEMARSIN, E
    COLLEN, D
    THROMBOSIS AND HAEMOSTASIS, 1990, 64 (01) : 53 - 60
  • [27] MODULATION OF THE MALIGNANT PHENOTYPE WITH THE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND THE TYPE-I PLASMINOGEN-ACTIVATOR INHIBITOR
    SORDAT, B
    REITER, L
    CAJOT, JF
    CELL DIFFERENTIATION AND DEVELOPMENT, 1990, 32 (03): : 277 - 286
  • [28] A COMPARISON OF THE PLASMINOGEN-ACTIVATOR ACTIVITY UNITS OF URINARY-TYPE PLASMINOGEN-ACTIVATOR (U-PA) AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA)
    CREIGHTONKEMPSFORD, LJ
    PRING, JB
    GAFFNEY, PJ
    BLOOD COAGULATION & FIBRINOLYSIS, 1992, 3 (04) : 481 - 483
  • [29] EFFECT OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 (PAI-2) ON NEOVASCULARIZATION
    WILIAMS, GA
    CHAPMAN, C
    CHENG, M
    SHETTLE, L
    OMALLEY, B
    TRESE, M
    HARTZER, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (04) : 1080 - 1080
  • [30] UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) IS INDEPENDENTLY RELATED TO OUTCOME IN COLORECTAL-CANCER
    SKELLY, MM
    MULCAHY, HE
    CONNELL, T
    TROY, A
    DUGGAN, C
    DUFFY, MJ
    SHEAHAN, K
    ODONOGHUE, DP
    GASTROENTEROLOGY, 1995, 108 (04) : A539 - A539
12345